Wehler, E., Lautsch, D., Kowal, S., Davies, G., Briggs, A., Li, Q., . . . Alsumali, A. (2020). Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin. Pharmacoeconomics.
Citação norma ChicagoWehler, Elizabeth, Dominik Lautsch, Stacey Kowal, Glenn Davies, Andrew Briggs, Qianyi Li, Swapnil Rajpathak, and Adnan Alsumali. "Budget Impact of Oral Semaglutide Intensification Versus Sitagliptin Among US Patients With Type 2 Diabetes Mellitus Uncontrolled With Metformin." Pharmacoeconomics 2020.
Citação norma MLAWehler, Elizabeth, et al. "Budget Impact of Oral Semaglutide Intensification Versus Sitagliptin Among US Patients With Type 2 Diabetes Mellitus Uncontrolled With Metformin." Pharmacoeconomics 2020.